This new report provides analysis of the global respiratory disease testing market, including emerging technologies, instrumentation review, volume and sales segment forecasts by country, supplier shares, and strategic profiles of leading competitors.
The report is available by section, and can be customized to specific information needs and budget.
This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
In addition to test volume and sales projections, the report presents market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
The report is available by section, and can be customized to specific information needs and budget.
About this Report
This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.
Current scientific views on epidemiology and etiology are presented for:
- Adenovirus
- Coronavirus
- Enterovirus
- Influenza
- Legionella
- Mononucleosis
- Mycoplasma
- Pneumonia
- RSV
- Rhinovirus
- Tuberculosis
The report provides test volume and sales forecasts by country and market segment, including:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
In addition to test volume and sales projections, the report presents market share estimates for major suppliers of respiratory disease diagnostic products, by test and country. Also, the report
- Examines market applications of molecular diagnostics, monoclonal antibodies, immunoassays, IT and other technologies.
- Reviews features and operating characteristics of major analyzers used for respiratory disease testing;
- Profiles key suppliers and potential market entrants developing innovative technologies and products
- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.
Methodology
The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
